Shares of Ajanta Pharma had touched 52-week high at Rs713.95, after the promoter acquired almost 1% stake in the company through open market purchases.
Gabs Investments Pvt Ltd, one of its promoters has acquired 115,431 shares representing 0.98% stake in the company via creeping acquisition route since April, according to disclosure made by the company on Monday.
The promoters hiked their stake by 3.31% to 70.13% in the last financial year ended March 2012.
Meanwhile, the stock has outperforming the market by gaining 32%, compared with 3.6% fall in the benchmark index, after reporting 52% year-on-year growth in net profit at Rs77 crore for the quarter ended March 2012.
The company’s board of directors have recommended a dividend @ Rs7.50 per share for the financial year 2011-12 and also splitting of its equity share of Rs10 each in to 2 equity shares of Rs5 each.
At 3.27 pm, Ajanta Pharma was trading at Rs709.20, up by 4.82%, with a volume of 0.47 lakh shares on the BSE.
....more info
Gabs Investments Pvt Ltd, one of its promoters has acquired 115,431 shares representing 0.98% stake in the company via creeping acquisition route since April, according to disclosure made by the company on Monday.
The promoters hiked their stake by 3.31% to 70.13% in the last financial year ended March 2012.
Meanwhile, the stock has outperforming the market by gaining 32%, compared with 3.6% fall in the benchmark index, after reporting 52% year-on-year growth in net profit at Rs77 crore for the quarter ended March 2012.
The company’s board of directors have recommended a dividend @ Rs7.50 per share for the financial year 2011-12 and also splitting of its equity share of Rs10 each in to 2 equity shares of Rs5 each.
At 3.27 pm, Ajanta Pharma was trading at Rs709.20, up by 4.82%, with a volume of 0.47 lakh shares on the BSE.
....more info